Abstract. The mucopolysaccharidoses (MPS) represent a group of inheritable, clinically heterogeneous lysosomal storage disorders, in which progressive accumulation of glycosaminoglycans (GAGs) can affect organs and tissues all over the body. The current paper discusses the skeletal X-ray and neuroimaging findings in MPS patients, and the imaging techniques that can be used for diagnosing and monitoring abnormalities in the skeleton and central nervous system. Most MPS types show a typical radiologic expression, called dysostosis multiplex, which manifests as malformations of the skeletal system involving bones in the skull, thorax, spine, pelvis, long bones, and hands. Abnormalities of the spine and GAG deposits in the meninges surrounding the spinal cord can result in spinal cord compression, which, if untreated, can lead to compressive myelopathy. Magnetic resonance imaging (MRI) is the most powerful imaging technique for detecting spinal cord compression, but also radiography and computed tomography are useful. GAG deposits in the brain and surrounding tissues can result in brain anomalies, i.e. white matter lesions, brain atrophy, and hydrocephalus, which can be detected using MRI. Skeletal X-ray and neuroimaging findings can play an important role in diagnosis, follow-up, surgical or medical planning, and assessment of treatment response in MPS patients. There is a need for standardized procedures in evaluating and monitoring neurologic complications in these patients.
Introduction
The mucopolysaccharidoses (MPS) represent a group of inheritable metabolic diseases, in which a deficiency of one or more of the enzymes involved in glycosaminoglycan (GAG) degradation results in the accumulation of undegraded or partly degraded GAGs in connective tissue. This accumulation progressively leads to widespread tissue and organ dysfunction, and ultimately results in premature death in the majority of patients [8] . Most MPS types are characterized by skeletal abnormalities and joint disease, the exception is the case of MPS III which is primarily central nervous system-related and has only mild dysostosis multiplex even in the most severely affected patients. Within the group that have moderate to severe dysostosis multiplex (ie MPS I, II, IV, VI and VII) the severity of the dysostosis multiplex is variable, even intrafamilially and is generally related to the phenotypic expression of the disease in each patient. It is not possible to accurately differentiate between MPS types based on specific skeletal X-ray or neuroimaging character-istics. Skeletal X-rays showing dysostosis multiplex are useful in suggesting MPS as a possible diagnosis or supporting the diagnosis when MPS is suspected. Diagnosis of MPS in general and determination of type requires demonstration of abnormal enzyme assay. Although not used in diagnosis of MPS or MPS type, MRI of brain and spine are critical for evaluating the complications of MPS (i.e. cervical spine compression and hydrocephalus) and the need for neurosurgical treatment. A genetic skeletal survey including skull (anteroposterior [AP], lateral), chest (AP), spine (AP and lateral), pelvis (AP), tubular bones (AP), and/or hands and feet (AP) showing dysostosis multiplex is useful in suggesting or supporting MPS as a possible diagnosis. Specific diagnosis of MPS disease and determination of subtype requires demonstration of an abnormal enzyme using enzyme assays. In addition, for patients with the diagnosis of MPS disease (particularly MPS I, II, IV, and VI), cervical spine instability should be evaluated shortly after diagnosis using lateral cervical spine X-ray with flexion and extension views. This exam is only repeated if clinically indicated or after enzyme replacement therapy or hematopoietic stem cell transplantation, which may increase joint or ligament flexibility. If the flexion/extension exam by skeletal Xray is not adequate for evaluation, CT scan with flexion/extension may be helpful. Skeletal X-ray followup exams may be required to evaluate specific clinical problems such as hip pain, scoliosis/ kyphosis, or genu valgum (knock knees) or other bone-related clinical problems. Although not used in diagnosis of MPS, MRI of brain and spinal cord are critical for evaluating the complications of MPS (i.e. cervical spine compression and hydrocephalus) and the need for neurosurgical treatment. These evaluations should be initiated at diagnosis for baseline assessment and then only repeated every one to three years depending on clinical severity or specific neurologic findings.
Skeletal abnormalities can result in dysmorphism and severe growth retardation, with the severity of these abnormalities varying from patient to patient. Other common features that are characteristic for most but not all MPS types include coarse facial features, vision and hearing impairment, specific organomegaly, heart valve disease, breathing difficulties, and neurologic problems [8] . The latter include carpal tunnel syndrome, spinal cord compression, and brain abnormalities (which can result in intellectual deficit in some MPS types).
The current paper gives an overview of the skeletal X-ray and neuroimaging findings in patients with MPS and discusses how skeletal X-ray and neuroimaging techniques can be used for diagnosing and/or monitoring skeletal dysplasia, spinal cord compression, and brain anomalies in these patients.
Dysostosis multiplex
Several MPS types and other storage disorders share characteristic skeletal features revealed by X-ray radiological examination that is described as dysostosis multiplex ( Table 1 ). The occurrences of any and some of these typical radiologic manifestations can indicate the presence of one of these disorders and warrant further clinical examination. In MPS, dysostosis multiplex generally involves malformations of the skull, thorax, spine, pelvis, long bones and hands. The more features of dysostosis multiplex that are present, the more likely that it represents a case of MPS disease.
The skull of patients with MPS often shows an abnormal J-shaped sella turcica and a thickened diploic space (Fig. 1) . The shape of the sella is characteristic, but not diagnostic of MPS disorders.
In the thorax, MPS often manifests as paddle-shaped (oar-shaped) ribs, which are widened anteriorly and tapered posteriorly (Fig. 2) . Also common, but less characteristic for MPS, are the short and thickened clavicles (Fig. 2) .
In the spine, dysostosis multiplex shows as multiple superiorly notched (inferiorly beaked) vertebrae, and often posterior scalloping, at the thoraco-lumbar junction (Fig. 3) . A combination of superior notching and posterior scalloping is very typical for MPS. In MPS IVA (Morquio syndrome), vertebral bodies are more typically middle-beaked. The pelvis of MPS patients is often characterized by rounded iliac wings and inferior tapering of the ilea (Fig. 4) , with the lateral aspect of the ileum merging and tapering into the acetabular roof region. Inferior tapering is very typical for MPS disorders. A newly discovered finding in MPS patients is a double wall in the lower ileal lateral walls (Fig. 4) .
The long bones of MPS patients often show mildly hypoplastic epiphyses (Fig. 5 ). Other long bone deformities include hypoplastic or fragmented capital femoral epiphyses, proximal humeral notching, long and narrow femoral necks that can be eroded on both the lateral and the medial sides, hypoplastic distal ulnae, and thickened short diaphyses.
The hands of MPS patients typically show proximally pointed metacarpals. Metacarpals can be short and thick with thin cortices, even if proximal pointing is not present. Nonspecific findings include hypoplastic and irregular carpal bones, and irregularly shaped tarsal bones (Fig. 6 ).
Skeletal X-ray and neuroimaging findings in the spine
In most MPS types, deformities of the spine and the skull base and GAG deposits in the tissues surrounding the spinal cord can result in spinal cord compression. If left untreated, spinal cord compression can lead to destruction of spinal cord tissue, also called compressive myelopathy, and in lumbar segment compression of neural roots. Spinal cord compression in MPS may involve multiple spinal cord levels, but is usually the result of spinal canal narrowing at the cervico-cranial or the thoraco-lumbar region (Fig. 7 ) [5, 10, 11, [14] [15] [16] . Alterations of the spinal anatomy can be identified using imaging techniques such as skeletal X-ray, computed tomography (CT), and magnetic resonance imaging (MRI). These imaging tools can also be useful for surgical or medical planning, and for assessing the impact of treatment. Conventional radiography provides twodimensional radiographic images of the skeleton and can be used to detect gross anomalies of the spine such as scoliosis, kyphosis (curvature of the upper spine or hunch back), abnormalities in cranio-cervical anatomy, spinal stenosis and spinal instability. It is particularly useful for helping to make an initial diagnosis. More subtle osseous anomalies can be identified using CT of the spine. This technique allows the generation of three-dimensional images from a large series of two-dimensional X-ray images. As is often done with cervical spine X-rays in extension and flexion positions, MRI and CT techniques can also be used for detecting dynamic instability and for surgical planning. When metal artefacts preclude high-quality MRI, then CT may be the preferred imaging technique. However, although CT is a powerful tool for imaging the bone, it is less potent when it comes to imaging soft tissue. The most powerful tool for imaging soft tissues such as the brain, the spinal cord, and the soft tissues including the meninges surrounding the cord is MRI, as it images the soft tissues more clearly and provides greater contrast between the different soft tissues in the body. It can be used for detecting the cause of spinal cord or nerve root compression, with the goal of planning surgical relief of these problems. In addition, it gives clues for practical and research purposes about disc disease and can be used for detecting abnormalities of the skull base and cranio-cervical instability. For routine imaging of the spine and the detection of spinal cord compression and injury in MPS patients, it is desirable that both T1 weighted axial and sagittal and T, weighted axial and sagittal MRI scans are performed. Steady State Free Procession (SSFP) is another useful tool for routine diagnosis in these patients. The latter technique produces MRI images with increased signal from fluid and can be used to detect cerebrospinal fluid with certainty. The detection of cerebrospinal fluid is particularly useful in patients where narrowing of the space between the spinal cord and the dura mater accelerates the movement of the cerebrospinal fluid. This acceleration causes a so called "dephasing" of the fluid, which shows black instead of white on T2 weighted sequence. In this case, it is impossible to distinguish whether the cerebrospinal fluid is either gone, which indicates spinal stenosis, or just dephased. The cerebrospinal fluid can also be imaged directly using contrast cisternography, or an MR phase contrast cerebrospinal fluid flow study can be performed to demonstrate the movement of the fluid and infer from that whether or not there is complete stenosis. When SSFP, cisternography, and the cerebrospinal fluid flow study cannot show the presence of cerebrospinal fluid, diffusion weighted imaging can be used to assess whether there is any restriction in the movement of water in the tissue [3] . Restriction of diffusivity in an area of spinal stenosis indicates tissue compression. An alteration in diffusivity might predict and correlate with early dysfunction of the cord, before the spinal cord is irreversibly damaged, and possibly even before the patient shows symptoms of spinal cord compression. Therefore, diffusion imaging might be useful as a tool for assessing the impact of surgical intervention or medical treatment. However, it yet needs to be elucidated whether this tool can also be used to measure improvements in diffusion after surgical or medical intervention. Other imaging techniques that can be useful for identifying alterations of the spinal cord include fluid-attenuated inversion recovery (FLAIR), and a number of dynamic techniques including dynamic flexion-extension, and possible diffusion tensor imaging (DTI).
Neuroimaging findings in the brain
Brain anomalies are common in MPS. Basically, the brain pathology in MPS is believed to be a consequence of complex mechanisms initiated by lysosomal accumulation of GAGs in neurons and microglia [9] . Common findings on brain MRI include brain atrophy, white matter lesions, and hydrocephalus (Fig. 8) [6, 17, 18] . Intellectual deficit is characteristic for MPS IH (Hurler syndrome), the severe forms of MPS II (Hunter syndrome) and VII (Sly syndrome), and all subtypes of MPS III (Sanfilippo syndrome). It can be due to brain atrophy, which provides a marker of axonal loss [12, 13] . Indeed, brain atrophy has been found to be more common in MPS I, II and III than in MPS VI [6, 12, 17] . Intellectual deficit is also suggested to be related to the presence of extensive white matter lesions [4, 17] . However, although MPS VI patients are usually not intellectually challenged, they can still show white matter lesions [2] . The appearing of these lesions probably involves the deposition of gangliosides (GM2 and GM3) in the brain [17] . White matter lesions have been shown to become more extensive with time, especially in MPS II patients, suggesting that it is a progressive phenomenon [17] . Enlarged ventricles might be the consequence of either brain atrophy and white matter disease or hydrocephalus. Typical symptoms of hydrocephalus include enlargement of the head, headaches, and vomiting, but it can also result in sudden blindness due to optic nerve compression and injury. However, MPS patients usually do not show typical clinical symptoms of hydrocephalus or papillary oedema (unpublished observations). Therefore, ventricle enlargement may more commonly be due to brain atrophy in these patients.
Brain involvement in MPS is usually suspected on the basis of intellectual delay by certain age milestones. In patients with severe MPS II, for example, the ability to sit, walk, and speak tend to occur later than in unaffected children [19] . However, as mentioned before, brain anomalies occurring in MPS patients are not limited to intellectual deficits in MPS patients; white matter lesions and ventricular enlargement have also been described for MPS VI patients who usually have normal intelligence [17] . The dysostosis multiplex finding of an abnormal J-shaped sella turcica appears to be also secondary to GAG accumulation with sella erosion.
Changes in brain morphology are generally assessed using MRI, which can provide accurate, reproducible and quantitative measures of brain atrophy, white matter lesion load, and ventricular size in vivo. It also allows monitoring of disease progression and therapeutic response as illustrated in Krabbe disease, which is another lysosomal storage disease characterized by central system degeneration [7] .
Imaging problems in MPS patients
MPS patients are among the most difficult patients for performing advanced imaging studies for a variety of reasons. First, many of these patients are intellectually challenged and not very cooperative. Moreover, airway problems are common in these patients, which can be a problem for general anaesthesia, as well as the previously mentioned cervical spine instability. If patients are not generally anesthetized, the imaging studies are often compromised by claustrophobia and motion artefacts, especially in young children. CT and MRI imaging of the thoracic spine is complicated by both cardiac and respiratory motion. Sagittal images are most useful for looking for stenosis, but the presence of scoliosis or kyphosis makes sagittal imaging very difficult. Finally, metal artefacts, such as spinal rods, can considerably compromise MRI.
Assessing skeletal X-ray and neuroimaging severity for MPS patients
No international standards for evaluating radiologic/imaging findings in MPS currently exist. However, regular and systematic evaluation of MPS patients using a reproducible scoring system could be very useful for evaluating and monitoring these patients, for surgical planning, and for measuring the impact of treatment. In addition, standardized evaluation of radiologic findings might provide a better insight into the natural course of bone disease, and spinal cord and brain involvement in the different MPS types. Some issues remain when it comes to quantifying dysostosis multiplex. Particularly the great variety in bone shapes among individuals including even interfamilial variability makes it very difficult to quantify subtle skeletal changes. Due to these issues, the development of a scoring system for dysostosis multiplex remains a major challenge that warrants further insight into the exact mechanisms that cause these typical skeletal features of MPS.
Some efforts have been made to develop MRI scoring systems for spinal cord and brain disease in MPS. A study presented at the Annual Symposium of the Society of Inborn Errors of Metabolism (SSIEM 2008) used a scoring system for spinal cord involvement that was developed at the Hospital de São João (Porto, Portugal) [1] . This scoring system includes cervical MRI findings of odontoid hypoplasia, peri-odontoid soft tissue mass, posterior longitudinal ligament hypertrophy, subluxation of the C1-C2 articulation, and thoracolumbar findings of the beaked vertebra, concavity of the vertebral body posterior wall, kyphosis and spinal cord involvement as measures for the prognosis and monitoring of the MPS patients and for taking treatment decisions (Table 2) . Another scoring system presented at SSIEM2008 was adapted from previous work for evaluating brain disease in MPS patients [2] . As measures of the brain involvement in MPS, this scoring system uses T2 weighted imaging hyperintense areas, cortical atrophy, enlargement of the supratentorial ventricles, enlarged periventricular spaces at the basal ganglia/thalamus, corpus callosum and white matter, optic nerve sheath enlargement and sella turcica enlargement (Table 3 ). In the past, comparable scoring systems have been used for clinical research in MPS patients [5, 10, 12] .
Conclusions
The MPS diseases are characterized by specific skeletal and CNS features that may be viewed by X-ray or advanced neuroimaging technology such as CT or MRI; the evaluation of which can make a large contribution to the diagnosis and follow-up of patients with MPS. These techniques can also be useful tools for surgical and medical planning and for assessing the impact of therapy. There is need for standardized procedures for evaluating and monitoring neuroimaging alterations in MPS patients, so that proper treatment can be offered before these alterations have caused irreversible damage. 
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